Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis

Fig. 2

Methylation of SRSF9. A Methylation status of seven methylation sites of SRSF9; B Relationship between the methylation level of cg06116271 and the expression of SRSF9; C Overall survival for patients with high and low methylation status at cg06116271; D mRNA level of SRSF9 in cells treated with SAM; E mRNA level of SRSF9 in cells treated with DAC. *P < 0.05, **P < 0.01, ****P < 0.0001 versus control group. SAM: S-Adenosyl methionine; DAC: Decitabine

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us